References
Tonelli M, Parkin P, Leduc D, Brauer P, Pottie K, Dunfield L, Jaramillo Garcia A, Martin W, Connor Gorber S, Ugnat AM, Thombs BD. Canadian task force on preventive health care. Recommendations on screening for developmental delay. Can Med Assoc J. doi:10.1503/cmaj.151437.
Warren R, Kenny M, Bennett T, et al. Screening for developmental delay among children aged 1-4 years: a systematic review. CMAJ Open. 2016;4:E20–7.
Guevara JP, Gerdes M, Localio R, et al. Effectiveness of developmental screening in an urban setting. Pediatrics. 2013;131:30–7.
van Agt HM, van der Stege HA, de Ridder-Sluiter H, et al. Acluster-randomized trial of screening for language delay in toddlers: on school performance and language developmentat age 8. Pediatrics. 2007;120:1317–25.
Lewin G, Morissette K, Dickinson J, Bell N, Bacchus M, Singh H, Tonelli M, Jaramillo Garcia A. Canadian task force on preventive health care. Recommendations on screening for lung cancer. CMAJ. 2016;188(6):425–32.
Bell N, Connor Gorber S, Shane A, Joffres M, Singh H, Dickinson J, Shaw E, Dunfield L, Tonelli M. Canadian task force on preventive health care. Recommendations on screening for prostate cancer with the prostate-specific antigen test. CMAJ. 2014;186(16):1225–34.
Pottie K, Rahal R, Jaramillo A, Birtwhistle R, Thombs BD, Singh H, Connor Gorber S, Dunfield L, Shane A, Bacchus M, Bell N, Tonelli M. Canadian task force on preventive health care. Recommendations on screening for cognitive impairment in older adults. CMAJ. 2016;188(1):37–46.
Siu AL, US Preventive Services Task Force. Screening for speech and language delay and disorders in children aged 5 years or younger: US preventive services task force recommendation statement. Pediatrics. 2015;136:e474–81.
Berkman ND, Wallace IF, Watson L, et al. Screening for speech and language delay and disorders in children age 5 years or younger: a systematic review for the U.S. services task force. Synthesis No. 120. Rockville, MD: Agency for Healthcare Research and Quality; 2015. AHRQ Publication 13–05197-EF-1.
Siu AL, US Preventive Services Task Force, Bibbins-Domingo K, et al. Screening for autism spectrum disorder in young children: US preventive services task force recommendation statement. JAMA. 2016;315:691–6.
McPheeters ML, Weitlauf A, Vehorn A, et al. Screening for autism spectrum disorder among young children: a systematic evidence for the US Preventive Services Task Force: synthesis no. 129 [AHRQ publication no. 13–05185-EF-1]. Rockville: Agency for Healthcare and Quality; 2016.
Moyer VA, Butler M. Gaps in the evidence for well-child care: a challenge to our profession. Pediatrics. 2004;114:1511–21.
Cohen E, Uleryk E, Jasuja M, Parkin PC. An absence of pediatric randomized controlled trials in general medical journals, 1985-2004. J Clin Epidemiol. 2007;60:118–23.
Cohen E, Goldman RD, Ragone A, Uleryk E, Atenafu EG, Siddiqui U, Mahmoud N, Parkin PC. Child vs adult randomized controlled trials in specialist journals. A citation analysis of trends, 1985-2005. Arch Pediatr Adolesc Med. 2010;164(3):283–8.
Rivara FP, Alexander D. Randomized controlled trials and pediatric research. Arch Pediatr Adolesc Med. 2010;164:296–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Patricia C. Parkin declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Rights and permissions
About this article
Cite this article
Parkin, P. Reflections on the Canadian Task Force on Preventive Health Care: Recommendations on Screening for Developmental Delay. Curr Dev Disord Rep 3, 171–173 (2016). https://doi.org/10.1007/s40474-016-0093-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40474-016-0093-7